China SXT Pharmaceuticals - ADR Financials

$2.44

$0.25 (11.19%)

As on 17-Sep-2026 16:09EDT

Market cap

$3 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-4.02	-2.35	-1.93	-0.08	-2.37	-1.32
Cash Flow from Investing Activities	-1.25	0.06	0.03	-0.01	-0.05	-5.81
Cash from Financing Activities	14.43	8.40	-2.62	2.94	1.63	12.41
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS ($)	-10.59	-1.35	-3.57	-13.75	-2.82	-0.18
Cash EPS ($)	-10.35	-1.32	-3.34	-13.17	-2.67	-0.15
Adjusted Book Value ($)	50.71	6.32	16.06	34.04	8.09	1.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-6.86	-0.96	-2.22	-0.19	-1.17	-0.08
Free Cash Flow per Share ($)	-6.86	-0.96	-2.23	-0.35	-1.20	-0.09

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	-26.26	-20.02	-17.69	-26.02	-26.57	-17.11
ROE (%)	-27.49	-22.50	-21.65	-38.15	-35.42	-21.67
ROA (%)	-22.00	-14.75	-11.76	-18.81	-16.85	-9.77
EBIT Margin (%)	-664.06	-152.53	-132.45	-276.82	-206.41	-45.99
Net Margin (%)	-578.49	-189.77	-160.67	-301.00	-220.43	-57.52
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-0.38	-0.10	-0.02	-0.24	-0.46	-0.07
EBIT Growth (%)	-168.24	-3.96	53.20	-1.62	-144.47	-63.82
Net Profit Growth (%)	-87.83	-6.62	47.79	-3.46	-108.72	73.29
EPS Growth (%)	-6.83	0.62	0.74	-3.87	-14.95	1.00
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-0.16	-1.84	-0.47	-0.02	0.00	-0.52
Price / Book Value	0.03	0.39	0.10	0.01	0.00	0.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	3.74	4.34	3.39	2.59	0.94	6.41
Close Price ($)	134.40	29,938.80	20,160.00	85,200.00	84,000.00	552,000.00
High Price ($)	83,758.80	68,374.80	112,500.00	684,000.00	684,000.00	1,536,000.00
Low Price ($)	100.01	3,600.00	18,720.00	27,000.00	34,200.00	266,400.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.04	0.06	0.19	0.26	0.65	0.00
Short term debt to equity ratio	0.01	0.05	0.17	0.23	0.65	0.00
Current Ratio	7.93	3.54	1.60	1.35	1.31	1.25
Quick Ratio	7.25	3.40	1.51	1.31	1.25	1.20
Interest Coverage	-113.13	-4.10	-4.69	-11.45	-146.38	-1.36

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	301.35	109.15	69.82	68.19	129.45	162.57
Asset Turnover	0.04	0.08	0.07	0.06	0.08	0.17
Receivable days	873.85	340.57	254.83	436.56	781.48	703.89
Inventory Days	777.08	217.77	178.17	188.97	260.63	165.14
Payable days	340.04	324.14	353.07	337.98	397.34	320.16
Cash Conversion Cycle	1,310.89	234.20	79.93	287.55	644.76	548.87